Nexiva Single Port 20 24G x 1.75
Becton Dickinson
Peripheral IV cathetersClosed integrated peripheral IV catheter system (single port, 20 G x 1.75 in / 45 mm) with blood control
Certifications
- Classified as a short Term intravascular therapeutic catheter and cleared in the United States via FDA 510(k) premarket notification for the BD Nexiva Closed IV Catheter System.
- CE Marked as a medical device for sale in Europe under the Medical Devices Directive 93/42/EEC or subsequent EU/UK medical device regulations, as indicated for the BD Nexiva closed IV catheter product family.
- Manufactured under Becton Dickinson’s global quality management system for medical devices, including controls for sterility assurance (ETO sterilization) and material biocompatibility.
- Conforms to relevant ISO standards for intravascular catheters and vascular access devices as documented in BD’s technical and regulatory filings.
- Classified as a short Term intravascular therapeutic catheter and cleared in the United States via FDA 510(k) premarket notification for the BD Nexiva Closed IV Catheter System.
- CE Marked as a medical device for sale in Europe under the Medical Devices Directive 93/42/EEC or subsequent EU/UK medical device regulations, as indicated for the BD Nexiva closed IV catheter product family.
- Manufactured under Becton Dickinson’s global quality management system for medical devices, including controls for sterility assurance (ETO sterilization) and material biocompatibility.
- Conforms to relevant ISO standards for intravascular catheters and vascular access devices as documented in BD’s technical and regulatory filings.
Closed integrated peripheral IV catheter system (single port, 20 G x 1.75 in / 45 mm) with blood control
Description
BD Nexiva Single Port 20G x 1.75\ (catalogue 383518) is a closed, integrated peripheral IV catheter system with BD Vialon catheter material and blood control technology. It combines the IV catheter, extension set, stabilization platform and needle-free connection in one pre-assembled system, designed to reduce blood exposure, support aseptic technique, enhance catheter stability and provide reliable peripheral vascular access for fluid administration, blood sampling and short-term therapy.
Bnefits
- Closed integrated IV catheter system designed to minimise blood leakage and exposure at insertion.
- Blood control feature (Y) helps reduce blood spillage and potential contamination when the needle is withdrawn.
- Pre-assembled all-in-one design combining catheter, extension set, stabilization platform and needle-free connector, reducing the need for separate add-on components.
- Catheter made from BD Vialon biomaterial, designed for improved dwell times and vessel compatibility compared with traditional Teflon catheters.
- Integrated soft, flexible stabilization platform helps reduce catheter movement in the vessel and improves patient comfort.
- High pressure rating up to 300 psi, suitable for many high-pressure infusion applications according to instructions for use.
- 20 G (pink hub) size with 1.75 in (45 mm) length supports reliable peripheral access and a gravity flow rate of approximately 51 mL/min.
- Sterile, single-use device supplied ready to use to support safe, efficient vascular access procedures.
Indications
- Short-term peripheral intravascular access (less than 30 days) in peripheral veins.
- Administration of intravenous fluids and medications via a peripheral IV line.
- Peripheral blood sampling through the closed IV catheter system when protocol allows.
- Monitoring of blood pressure or other hemodynamic parameters via a peripheral catheter when clinically appropriate and in line with local protocols.
- Use in hospital and clinical environments where closed IV systems are preferred to support infection prevention and reduction of blood exposure.
Composition
- Catheter fabricated from BD Vialon catheter biomaterial (a proprietary polyurethane-based material).
- Integrated extension tubing forming a closed single-lumen fluid pathway from catheter to connector.
- Integrated soft, flexible stabilization platform attached to the catheter hub.
- Needle with passive needle-shielding mechanism (safety technology) within the closed system.
- Needle-free connection component appropriate to the Nexiva configuration (single port system).
- Sterile packaging components suitable for ethylene oxide (ETO) sterilization.
Formulation
- Closed, integrated peripheral IV catheter system with single port design.
- 20 G catheter with nominal outer diameter approximately 1.1 mm and inner diameter range approximately 0.79–0.86 mm.
- Catheter length 1.75 in (approximately 45 mm) for standard adult peripheral venous access.
- Blood control (Y) feature integrated into the catheter hub to limit backflow of blood during needle withdrawal.
- Gravity flow rate specification of approximately 51 mL/min at standard test conditions.
- High pressure rating up to 300 psi for pressure-infusor or injector-compatible use as defined in the product’s instructions.
- Pink colour-coded hub indicating 20 G size according to ISO colour conventions.
- Sterilised by ethylene oxide (ETO) and supplied sterile for single use.
Packaging
- Individual sterile units: each catheter system supplied in a sterile blister or peel pack.
- Box quantity: 20 Nexiva Single Port 20G x 1.75" catheter systems per box.
- Case quantity (manufacturer packaging): 80 catheter systems per case (4 boxes of 20).
- Labelling includes gauge, length, hub colour, catalogue number 383518, lot number, expiry date and sterilization method.
Usage
- For use only by trained healthcare professionals experienced in peripheral IV catheter insertion and familiar with BD Nexiva Closed IV Catheter System instructions for use.
- Inspect the outer carton and individual sterile package before use; do not use if the packaging is damaged, opened or if labelling is illegible or past the expiry date.
- Prepare all required equipment and perform hand hygiene according to institutional policy and aseptic non-touch technique (ANTT) or equivalent aseptic standard.
- Select an appropriate peripheral vein and site, considering vessel size, therapy type, expected duration of catheterisation and patient factors.
- Disinfect the insertion site using an approved skin antiseptic (for example, 2% chlorhexidine in 70% alcohol) and allow to dry completely before puncture.
- Insert the Nexiva catheter using the recommended insertion technique (e.g., BD Nexiva single port insertion protocol), observing for blood flashback to confirm venous entry.
- Advance the catheter into the vessel while withdrawing the needle; as the needle is withdrawn, allow the passive safety mechanism and blood control feature to activate as designed.
- Stabilise the catheter with the integrated platform and secure using sterile adhesive dressings and securement devices in line with local vascular access policies.
- Flush the system with sterile saline, verify patency and absence of resistance or swelling, and attach IV tubing or caps / needle-free connectors as appropriate.
- Monitor the peripheral IV site regularly for signs of complication (pain, redness, swelling, leakage, phlebitis, infiltration or infection) and remove the catheter promptly if complications occur or when therapy is complete.
- Dispose of the used catheter system, needles and packaging components as clinical sharps and medical waste according to local regulations; do not attempt to resterilise or reuse.
- Always refer to the latest BD Nexiva Closed IV Catheter System electronic Instructions for Use (eIFU) and institutional policies for full insertion, maintenance and removal instructions.
Contraindications
- Do not insert into limbs or sites with known or suspected infection, thrombosis, significant edema, compromised circulation or lymphedema unless specifically directed by a clinician aware of the risks.
- Avoid insertion distal to an existing infiltrated or phlebitic site, or through areas of burn, dermatitis, broken skin or active dermatologic disease.
- Not intended for long-term central venous access or for use in arteries or other non-peripheral vessels.
- Patients with known hypersensitivity to any material in the device (for example, polyurethane-based catheter materials or components of the stabilization platform) should not receive this catheter.
- Use with high-pressure power injectors must adhere strictly to product pressure rating and connector type; do not exceed the specified pressure rating of 300 psi.
- Any additional contraindications or restrictions stated in the BD Nexiva Closed IV Catheter System instructions for use should be observed.
Adverse Effects
- Local pain, discomfort or tenderness at or around the insertion site.
- Erythema, warmth, swelling or induration consistent with phlebitis or local irritation.
- Infiltration or extravasation of fluids into surrounding tissue, potentially causing swelling and discomfort.
- Hematoma formation or bruising at the insertion site due to vessel injury.
- Catheter occlusion, blockage or inability to flush or infuse through the device.
- Infection at the catheter site or catheter-related bloodstream infection if aseptic technique or maintenance are inadequate.
- Allergic or hypersensitivity reactions to device materials in susceptible individuals.
- Air embolism, fluid overload or other infusion-related systemic complications if not used according to safe infusion practices.
- Rare but serious complications such as nerve injury or compartment syndrome, typically associated with malposition, infiltration or extravasation.
- Any other adverse events described in the official BD Nexiva Closed IV Catheter System instructions for use should be considered as potential risks.
Storage Conditions
- Store in a clean, dry environment at typical controlled room temperature conditions indicated on the packaging (for example, approximately 15–30 °C); avoid extremes of heat and cold.
- Keep in original cartons and sterile unit packaging until point of use to maintain sterility and protect from physical damage and contamination.
- Protect from direct sunlight, moisture and crushing or bending that could damage the catheter or packaging.
- Do not use the product after the labelled expiry date.
- Do not use if the sterile barrier appears compromised, packaging is torn, wet or otherwise damaged, or if there is visible damage to the device.
Duration
Designed for short-term peripheral IV use, with dwell times typically up to 72\u2013144 hours depending on institutional policy, patient condition, vein quality and clinical assessment; actual duration should follow local vascular access guidelines and clinical judgement.
Onset
Provides immediate intravascular access upon successful catheter placement, allowing fluids, medications or blood sampling to commence as soon as patency and correct placement are confirmed.
